Phase 1 High Grade Serous Ovarian Cancer Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Endometrial CancerPrimary Peritoneal CarcinomaNon-small Cell Lung Cancer+6 more
Genmab764 enrolled66 locationsNCT05579366
Recruiting
Phase 1
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Esophageal Squamous Cell CarcinomaHead and Neck Squamous Cell CarcinomaHigh Grade Serous Ovarian Cancer
IDEAYA Biosciences150 enrolled5 locationsNCT07503808
Recruiting
Phase 1
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
High Grade Serous Ovarian Cancer
Institute of Cancer Research, United Kingdom33 enrolled3 locationsNCT06976892